Pfizer may apply for emergency use of COVID-19 vaccine by late November
The company expects to have data on the drug's safety by the third week of November.
Trump's election-eve drug discounts for seniors get snagged
One administration official said the odds are 75-25 the plan will not happen
Pelosi, Mnuchin reach agreement on Democrats' language for national COVID testing plan
A Treasury Department official familiar with the matter told FOX Business that the language of the plan will be shared on Friday.
Walmart now offering Medicare plans as election season heats up
America’s largest retailer, Walmart, is adding Medicare health insurance plans to its plethora of goods (or commodities). And with the start of this year’s Annual Enrollment Period (AEP), seniors can officially start enrolling through the company’s new brokerage.
Walgreens completes 1M coronavirus tests, ramps up corporate testing
Walgreens is offering COVID-19 tests to main street consumers and big businesses.
Regeneron gets approval for 1st Ebola virus treatment
Regeneron's treatment is a combination of three antibodies that work by killing the virus
Biden camp denies report that son-in-law advised on health policy while investing in coronavirus startups
Democratic presidential nominee Joe Biden's campaign pushed back on a report that the candidate's son-in-law advised the team on the coronavirus pandemic and health policy while simultaneously investing in health care startups.
FDA issues warning to 5 companies selling dietary supplements containing cesium chloride
The FDA requires companies to provide safety-related information about cesium chloride before it is included in a dietary supplement.
FDA faults quality control at Lilly plant making Trump-touted COVID drug
The Lilly antibody therapy, which is experimental and not yet approved by regulators as safe and effective, is similar to a drug from Regeneron Pharmaceuticals that was given to the president during his bout with COVID-19.
Johnson & Johnson coronavirus vaccine trial pause 'quite common,' Alex Azar says
The pause on Johnson & Johnson’s coronavirus vaccine research study, which is due to an adverse reaction by one of the participants, is “quite common” in vaccine clinical trials, Health and Human Services Secretary Alex Azar told “Varney & Co.” on Tuesday.
Eli Lilly pauses COVID-19 antibody trial, stock slides
Eli Lilly stock fell more than 4 percent following the news
Johnson & Johnson posts strong third quarter earnings after pause in coronavirus vaccine study
Johnson & Johnson reported a strong third quarter performance on Tuesday following an announcement that it is pausing its coronavirus vaccine research study.
Dems warn Barrett confirmation means doom for ObamaCare, but 'severability' doctrine might save it
Democrats, since Amy Coney Barrett was announced as the Supreme Court nominee, have hammered the message that if she is confirmed Barrett could be the deciding vote in California v. Texas, a constitutional challenge to the Affordable Care Act (ACA) being pushed by red states who say the individual mandate in the law is unconstitutional.
Investors prepare for higher Treasury yields as election looms
The prospect of a Democratic sweep in next month’s elections is helping to push U.S. government-bond yields higher, stirring memories of four years ago when yields climbed sharply after a Republican victory.
Johnson & Johnson Covid-19 vaccine study paused due to illness
Johnson & Johnson paused its coronavirus vaccine research study due to an adverse reaction by one of the participants and would not provide further comment on the issue.
COVID-19 pandemic to cost Americans roughly $16 trillion, study says
The deadly coronavirus pandemic will ultimately cost Americans an estimated $16 trillion, according to a new study released Monday.
Regeneron officials sell $1M in stock after Trump calls COVID-19 treatment drugs 'miracles'
Securities and Exchange Commission filings show that two executives at Regeneron, a biotech company at the cutting edge of coronavirus treatment, netted about $1 million through sales of the company's stock after President Trump praised what he described as Regeneron's coronavirus "cure."
Dems frame Amy Coney Barrett as threat to ObamaCare during confirmation hearing
Senate Democrats made the Affordable Care Act the centerpiece of their effort to block the confirmation of Judge Amy Coney Barrett to the Supreme Court on Monday, portraying her as a threat to the landmark health care law passed more than a decade ago.
Bill Gates says Trump's coronavirus treatment won't work for everyone, shouldn't be called 'cure'
Microsoft co-founder and billionaire philanthropist Bill Gates said Sunday that the Regeneron antibody cocktail administered to President Trump to treat a case of COVID-19 shouldn't be referred to as a "cure."
Regeneron CEO says President Trump's antibody cocktail treatment is 'case report'
Regeneron CEO Leonard Schleifer said Sunday that the ability of the company's antibody cocktail that was administered to President Trump to treat a case of coronavirus was merely a "case report" or singular occurrence, despite the president calling the experimental drug a "cure."


















